Drug
Trifarotene clinical trials
- studies test it
- 14
- open now
- 0
- in phase 3
- 6
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
14 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 6
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 1
Galderma R&D (9) · Taro Pharmaceuticals USA (2) · Teva Pharmaceuticals USA (1) · M.D. Anderson Cancer Center (1) · Mayne Pharma International Pty Ltd (1)
Studies
Open first, then newest update. How each study uses trifarotene is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne VulgarisActive, not recruitingPhase 3Galderma R&DNCT07186413Written as Trifarotene
- A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne VulgarisCompletedPhase 1Taro Pharmaceuticals USANCT06733402Written as Trifarotene Cream 0.005%
- Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne VulgarisCompletedPhase 3Teva Pharmaceuticals USANCT05550337Written as Trifarotene 0.005 % Topical Cream
- Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar FormationCompletedPhase 4Galderma R&DNCT04856904Written as Trifarotene Cream
- AkLief Evaluation in Acne-induced Post-Inflammatory HyperpigmentationCompletedPhase 4Galderma R&DNCT05089708Written as Trifarotene Cream
- A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne VulgarisCompletedPhase 1Taro Pharmaceuticals USANCT06063473Written as Trifarotene Cream 0.005%
- A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar IchthyosisTerminatedPhase 2Mayne Pharma International Pty LtdNCT03738800Written as CD5789 Cream 200 µg/g
- A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)CompletedPhase 4Galderma R&DNCT04451330Written as Trifarotene cream
- Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne VulgarisCompletedPhase 3Galderma R&DNCT03915860Written as Trifarotene
- Dose Range Study of CD5789 in Acne VulgarisCompletedPhase 2Galderma R&DNCT01616654Written as CD5789 25 µg/g cream
- CD5789 (Trifarotene) Long Term Safety Study on Acne VulgarisCompletedPhase 3Galderma R&DNCT02189629Written as CD5789 (trifarotene)
- Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne VulgarisCompletedPhase 3Galderma R&DNCT02566369Written as CD5789 (trifarotene) 50μg/g cream
- Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne VulgarisCompletedPhase 3Galderma R&DNCT02556788Written as CD5789 (trifarotene) 50µg/g Cream
- CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)CompletedPhase 1M.D. Anderson Cancer CenterNCT01804335Written as CD5789 0.01% Cream
Codes
What other systems call trifarotene · ClinicalTrials.gg INT001022
- MeSH (NLM) C000629420trifaroteneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0J8RN2W0HKTRIFAROTENEConfirmed FDA, NLM, Wikidata
- RxNorm 2205637Confirmed FDA, Wikidata
- Wikidata Q27236856trifaroteneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C118577TrifaroteneOne source FDA
- DrugBank DB12808One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629420 | trifarotene | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0J8RN2W0HK | TRIFAROTENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2205637 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27236856 | trifarotene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C118577 | Trifarotene | One source FDA |
| DrugBank | DB12808 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.